CD8A and glioblastoma: Our data demonstrated that combination M002 and anti-PD1 results in an increased infiltration of CD8+ cells over control mice in the tumor region, which is consistent with previously reported findings on combination oHSV and ICI immune promotion in preclinical GBM 14.